CompletedNCT02968602
This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT02118610
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT00492349
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT05179525
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Condition
- Schizophrenia
Active Not RecruitingNCT04829292
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 12 Years to 30 Years
- Countries
- Canada
- Sponsor
- University of Calgary
- Condition
- Schizophrenia
CompletedNCT05227118
This study exists to better understand the safety of the medication MK-8189 and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication MK-8189 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 65 Years to 85 Years
- Countries
- United States
- Sponsor
- Merck Sharp & Dohme LLC
- Condition
- Schizophrenia
RecruitingNCT05847192
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 65 Years to 85 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
CompletedNCT06068465
This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherOver 40 Years
- Countries
- China
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Condition
- Schizophrenia
CompletedNCT05114733
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 12 Years to 22 Years
- Countries
- United States
- Sponsor
- Beth Israel Deaconess Medical Center
- Condition
- Schizophrenia
CompletedNCT06567587
This study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can improve sleep, daily rhythms, and longer-term stability.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Egypt
- Sponsor
- Tanta University
- Condition
- Schizophrenia
CompletedNCT05310981
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- Canada
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Condition
- Schizophrenia
CompletedNCT04949542
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- University of Washington
- Condition
- Schizophrenia
Enrolling By InvitationNCT05509998
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 12 Years to 30 Years
- Countries
- United States
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Condition
- Schizophrenia
Not Yet RecruitingNCT07041463
This study exists to understand how psychoeducation, a guided learning and support program, holds up over time after the earliest research stage. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Hôpital le Vinatier
- Condition
- Schizophrenia
CompletedNCT04132557
This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOther
- Countries
- United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Schizophrenia
Not Yet RecruitingNCT07025499
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.
SchizophreniaOtherOver 18 Years
- Countries
- Canada
- Sponsor
- McMaster University
- Condition
- Schizophrenia
Enrolling By InvitationNCT06655688
This study exists to see whether acceptance and commitment therapy, a talking treatment, can play a useful role in care. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Turkey
- Sponsor
- Saglik Bilimleri Universitesi
- Condition
- Schizophrenia
CompletedNCT04188366
This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Washington State University
- Condition
- Schizophrenia
Not Yet RecruitingNCT06928935
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherFrom 16 Years to 29 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Schizophrenia
RecruitingNCT04889911
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 15 Years to 24 Years
- Countries
- United States
- Sponsor
- John Jay College of Criminal Justice, City University of New York
- Condition
- Schizophrenia
WithdrawnNCT02492074
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- Germany
- Sponsor
- Central Institute of Mental Health, Mannheim
- Condition
- Schizophrenia
RecruitingNCT06802952
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 13 Years to 35 Years
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
- Condition
- Schizophrenia
CompletedNCT04292223
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherOver 40 Years
- Countries
- United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
RecruitingNCT05728138
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- Pakistan
- Sponsor
- Pakistan Institute of Living and Learning
- Condition
- Schizophrenia
RecruitingNCT05995782
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherOver 19 Years
- Countries
- South Korea
- Sponsor
- 1ST Biotherapeutics, Inc.
- Condition
- Schizophrenia